These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4609824)

  • 41. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
    Sethi KK; Brandis H
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of target proteins participating in a lectin-dependent macrophage-mediated cytotoxic reaction.
    Ohkuma Y; Komano H; Natori S
    Cancer Res; 1985 Jan; 45(1):288-92. PubMed ID: 3965139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
    Maliugina LL; Pol'kina RI
    Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803
    [No Abstract]   [Full Text] [Related]  

  • 48. [Localized irradiation on tumors and immune cell reactions--histoenzymatic evaluation using MM 46 tumor and Ehrlich tumor-bearing C3H/He mice].
    Imanaka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):355-69. PubMed ID: 6866746
    [No Abstract]   [Full Text] [Related]  

  • 49. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R
    Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors influencing the effect of an adjuvant on the growth of solid isogeneic tumors.
    Donner M; Hottier D; Burg C
    Eur J Cancer (1965); 1972 Apr; 8(2):141-7. PubMed ID: 4561332
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on the tumor-host relationship. IV. Tumor cell agglutination with survival mouse serum.
    Tanino T; Tsumita T
    Jpn J Exp Med; 1972 Aug; 42(4):401-13. PubMed ID: 4341690
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumour resistance of mice infected with salmonella enteritidis 11RX. The role of peritoneal exudate cells.
    Ashley MP; Hardy D
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):801-9. PubMed ID: 4596243
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 55. Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.
    Nomoto K; Yoshikumi C; Matsunaga K; Fujii T; Takeya K
    Gan; 1975 Aug; 66(4):365-74. PubMed ID: 1183773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of phytohaemagglutinin on the antibody response in mice bearing ascites tumor.
    Mekori T; Robinson E
    Oncology; 1973; 28(6):481-91. PubMed ID: 4771000
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunopotentiation of tumor-bearing and toxohormone treated mice by human ceruloplasmin.
    Itoh O; Torikai T; Satoh M; Okumura O; Osawa T
    Gan; 1981 Oct; 72(5):673-8. PubMed ID: 6976910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
    Yarkoni E; Bekierkunst A; Asselineau J; Toubiana R; Toubiana MJ; Lederer E
    J Natl Cancer Inst; 1973 Aug; 51(2):717-20. PubMed ID: 4765386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.